HERE TO EXPLAIN
RELAPSING MS.

The more you know about relapsing forms of multiple sclerosis, the greater understanding you’ll have about how to manage therapy to fit your life. Get started by educating yourself on these key topics of the disease:

What is MS?
What causes MS?
What are the symptoms of MS?
What is the difference between Relapsing-Remitting Multiple Sclerosis (RRMS) and Clinically Isolated Syndrome (CIS)?
What are the risk factors of MS?
When should I seek treatment for relapsing MS?

Newly diagnosed with relapsing MS?
Learn helpful tips from an MS specialist:

What is MS?^1-3

MS is most commonly known as a disease that affects the central nervous system (CNS), but two systems are involved in MS—the CNS and the immune system.

The nervous system has 2 main parts:

The central nervous system (CNS) is made up of the brain and spinal cord.
The peripheral nervous system (PNS) is made up of nerves that branch off from the spinal cord and extend to all parts of the body.

Neurons, or nerve cells, send signals through the CNS to other parts of the body along nerve fibers called axons. These signals control physical functions like balance and muscle coordination, as well as memory and other cognitive abilities.

The immune system consists of unique types of cells such as T cells and B cells and proteins designed to identify and destroy infectious organisms and other invaders and incorrectly functioning cells.

What causes MS?^1,4-6

Currently, the exact cause of MS is unknown. Inflammatory T cells attack the myelin that protects the axons, or nerve tissue, in the CNS. This results in scar tissue called scleroses (lesions) and disrupts the body’s ability to send signals from one part of the CNS to another, causing MS symptoms.

A diagram about the autoimmune response to multiple sclerosis

What are the symptoms of MS?^5-7

MS symptoms are highly individual, just like MS patients. They are unpredictable and vary from one person to another. The symptoms you may experience vary, depending on the location and the extent of the damage in your central nervous system. You may find that you experience some of the symptoms at different times during the course of MS. The most common MS symptoms are:

weakness
fatigue
numbness or tingling
walking (gait) difficulties
spasticity
dizziness
vision problems
bladder problems
bowel problems
depression
memory loss
difficulty concentrating

What is the difference between relapsing-remitting Multiple Sclerosis (RRMS) and Clinically Isolated Syndrome (CIS)?^8-11

A person diagnosed with MS has damage in at least 2 separate areas of the CNS which occurred at different points in time and all other possible diagnoses have been ruled out.

RRMS is the most common form of MS, affecting approximately 85% of people with MS. Two or more attacks (relapses), are usually followed by partial or complete recovery. During remissions, there is no progression of disease and all symptoms may disappear.

People diagnosed with CIS may experience only 1 attack, or event, of MS-like symptoms and may have brain lesions consistent with MS. Clinical studies have shown that treatment following a diagnosis of CIS can delay a second attack, thereby delaying the diagnosis of clinically definite relapsing MS. Starting treatment at an early stage and continuing treatment with an approved relapsing MS therapy can reduce relapses and may help reduce future damage from the outset.

What are the risk factors of MS?^12-14

Based on the worldwide distribution of MS, scientists have identified factors that may provide clues to the possible causes of MS. These include the following:

Gender: Women are 2 to 3 times more likely to have MS than men.
Genetics: MS is not directly inherited; however, the risk of getting MS rises in people who have a close relative (parent, sibling, or child) with MS.
Age: Most people are diagnosed with MS between the ages of 20 and 50.
Ethnic background: MS affects most ethnic groups, but it is more common among people of northern European ancestry.
Geography: MS occurs more frequently in people who live farther from the equator. Worldwide, more than 2.3 million individuals may be affected.

When should I seek treatment for relapsing MS?¹⁵

According to the National Multiple Sclerosis Society (NMSS):
Your doctor may consider starting treatment with an approved therapy as soon as possible after a diagnosis of relapsing MS, or after a first attack with magnetic resonance imaging (MRI) findings consistent with MS, and other possible causes have been ruled out.

Shared Solutions^®

Financial Support

Use

COPAXONE^® is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not use COPAXONE^® if you are allergic to glatiramer acetate or mannitol.

Serious side effects may happen right after or within minutes after you inject COPAXONE^® at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.

You can have chest pain as part of an immediate post-injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using COPAXONE^®. Call your doctor right away if you have chest pain while using COPAXONE^®.

Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use COPAXONE^®. Damage to the fatty tissue under your skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by following your doctor’s instructions for how to use COPAXONE^® and choosing a different injection area each time you use COPAXONE^®.

Liver problems, including liver failure, can occur with COPAXONE^®. Call your healthcare provider right away if you have symptoms, such as nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, or sleepiness.

The most common side effects of COPAXONE^® include redness, pain, swelling, itching, or a lump at the injection site; rash; shortness of breath; flushing; and chest pain.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of COPAXONE^®. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information in the full Prescribing Information.

References:

What is an immune-mediated disease? National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/Definition-of-MS/Immune-mediated-disease
What are the parts of the nervous system? Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) website. Accessed August 24, 2020. https://www.nichd.nih.gov/health/topics/neuro/conditioninfo/parts
How the brain works. Johns Hopkins website. Accessed August 24, 2020. https:/www.hopkinsmedicine.org/neurology_neurosurgery/centers_clinics/brain_tumor/about-brain-tumors/how-the-brain-works.html
Multiple sclerosis. Mayo Clinic website. Accessed August 24, 2020. https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269
MS the disease. National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/About-the-Society/Press-Room/MS-the-Disease
Definition of MS. National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/Definition-of-MS
MS symptoms. National Multiple Sclerosis Society website. Accessed August 24, 2020. https:/www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms
Diagnosing MS. National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/Symptoms-Diagnosis/Diagnosing-MS
Relapsing-remitting MS (RRMS). National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org//What-is-MS/Types-of-MS/Relapsing-remitting-MS
Clinically isolated syndrome (CIS). National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/Types-of-MS/Clinically-lsolated-Syndrome-(ClS)
Treatments of CIS. National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/Types-of-MS/Clinically-Isolated-Syndrome(ClS)/Treatments
Who gets MS? (Epidemiology). National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/Who-Gets-MS
What causes MS? National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/What-Causes-MS
Multiple sclerosis FAQs. National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/What-is-MS/MS-FAQ-s
The use of disease-modifying therapies in multiple sclerosis: principles and current evidence. National Multiple Sclerosis Society website. Accessed August 24, 2020. https://www.nationalmssociety.org/getmedia/1e64b96c-9e55-400e-9a64-0cdf5e2d60fe/summaryDMTpaper-_final

Injections for 3-times-a-week COPAXONE^® 40 mg must be at least 48 hours apart.

COPAXONE Co-pay Solutions^® Program Rules for COPAXONE^® (Glatiramer Acetate Injection) 20 mg—Patient Eligibility, Terms and Conditions: Valid only for qualified patients with a valid prescription for COPAXONE^® 20 mg/mL. No substitutions permitted. This card is valid only for patients with commercial insurance coverage for COPAXONE^® 20 mg/mL. This card is not valid for prescriptions paid for in part or in full by any state or federally funded program, including but not limited to, Medicare or Medicaid, Medigap, VA, DoD, TRICARE, the Puerto Rico Government Health Insurance Plan or by private health insurance plans or programs which reimburse you for the entire costs of your prescription drugs. This card is not valid for patients who are Medicare eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees (i.e., you are eligible for Medicare Part D but receive a prescription drug benefit through a former employer). Cash Discount Cards and other non-insurance plans are not valid as primary under this offer. Commercially insured patients pay as little as $0 on each fill. Maximum benefit and quantity limits apply. Offer expires on 12/31/21. Your acceptance of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or other third-party payer, and you agree to report acceptance of this offer to your health insurer, health plan, or third-party payer as may be required. Offer limited to one card per person and may not be used with any other discount, coupon or offer. Offer is not transferable. It is illegal to sell, purchase, trade or counterfeit this card. This card is not health insurance. This card is the property of Teva Neuroscience, Inc. and must be returned upon request. Offer valid only in the United States or the Commonwealth of Puerto Rico at participating retail, mail order and specialty pharmacies. For California patients, offer not valid unless the patient has satisfied any prior authorization or step therapy requirements imposed by the insurer. Void in Massachusetts and in any other state where prohibited by law, taxed, or restricted. Teva Neuroscience, Inc. reserves the right to change, rescind, revoke, or discontinue this offer at any time without notice.

COPAXONE Co-pay Solutions^® Program Rules for COPAXONE^® (Glatiramer Acetate Injection) 40 mg—Patient Eligibility, Terms and Conditions: Valid only for qualified patients with a valid prescription for COPAXONE^® 40 mg/mL. No substitutions permitted. This card is valid only for patients with commercial insurance coverage for COPAXONE^® 40 mg/mL. This card is not valid for prescriptions paid for in part or in full by any state or federally funded program, including but not limited to, Medicare or Medicaid, Medigap, VA, DoD, TRICARE, the Puerto Rico Government Health Insurance Plan or by private health insurance plans or programs which reimburse you for the entire costs of your prescription drugs. This card is not valid for patients who are Medicare eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees (i.e., you are eligible for Medicare Part D but receive a prescription drug benefit through a former employer). Cash Discount Cards and other non-insurance plans are not valid as primary under this offer. Commercially insured patients pay as little as $0 on each fill. Maximum benefit and quantity limits apply. Offer expires on 12/31/21. Your acceptance of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or other third-party payer, and you agree to report acceptance of this offer to your health insurer, health plan, or third-party payer as may be required. Offer limited to one card per person and may not be used with any other discount, coupon or offer. Offer is not transferable. It is illegal to sell, purchase, trade or counterfeit this card. This card is not health insurance. This card is the property of Teva Neuroscience, Inc. and must be returned upon request. Offer valid only in the United States or the Commonwealth of Puerto Rico at participating retail, mail order and specialty pharmacies. For California patients, offer not valid unless the patient has satisfied any prior authorization or step therapy requirements imposed by the insurer. Void in Massachusetts and in any other state where prohibited by law, taxed, or restricted. Teva Neuroscience, Inc. reserves the right to change, rescind, revoke, or discontinue this offer at any time without notice.

autoject^®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

HERE TO EXPLAINRELAPSING MS.

Newly diagnosed with relapsing MS?Learn helpful tips from an MS specialist:

What is MS?1-3

What causes MS?1,4-6

What are the symptoms of MS?5-7

What is the difference between relapsing-remitting Multiple Sclerosis (RRMS) and Clinically Isolated Syndrome (CIS)?8-11

What are the risk factors of MS?12-14

When should I seek treatment for relapsing MS?15